Top rated glioblastoma clinical trials in New York, New York
Here are the top 10 medical studies for glioblastoma in New York, New York
Popular filter options for glioblastoma new-york trials
Phase 3 Clinical Trials
View 88 phase 3 medical studies.
Alkylating agents
Lomustine + Standard Therapy for Glioblastoma
Recruiting2 awardsPhase 3
New York, New York
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Monoclonal Antibodies
SIACI Bevacizumab + Temozolomide and Radiation for Glioblastoma
Recruiting2 awardsPhase 3
New York, New York
This trial is testing whether a new treatment for brain cancer, which involves repeatedly injecting a drug directly into the brain, is more effective than the current standard of care.
Chemotherapy
Ultrasound-Assisted Chemotherapy for Glioblastoma
Recruiting2 awardsPhase 3
New York, New York
This trial will test a device using ultrasound to open the blood-brain barrier to allow more drugs to reach brain tumours, and assess the increased efficacy of carboplatin in treating recurrent glioblastoma.
CAR T-cell Therapy
Personalized Immunotherapy for Glioblastoma
Recruiting1 awardPhase 2 & 3
Newark, New Jersey
This trial will study an immunotherapy combining a cancer-patient's own cells and standard treatment to fight glioblastoma. Immune cells will be harvested from the patient, stimulated and expanded, then infused back.
Clinical Trials With No Placebo
View 88 medical studies that do not have a placebo group.
Monoclonal Antibodies
Intra-arterial Cetuximab for Newly Diagnosed Glioblastoma
Recruiting3 awardsPhase 1 & 2
New York, New York
This trial is a study to see if a new treatment for brain cancer is safe and effective. The new treatment is a combination of standard chemotherapy and radiation therapy, with an additional drug given through a direct infusion into the brain.
Monoterpene
Perillyl Alcohol for Glioblastoma
Recruiting1 awardPhase 1 & 2
New York, New York
This trial is testing a new way to administer a drug, perillyl alcohol, to patients with brain tumors. The goal is to see if it is safe and effective. Up to 24 patients will be enrolled in the first phase of the trial, and 25 in the second phase. The drug will be administered four times a day for 28 days, and patients will be monitored for side effects and effectiveness.
View More Glioblastoma New-york Trials
See another 70 medical studies focused on glioblastoma new-york.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.